4.7 Review

Bile Acid Signaling in Neurodegenerative and Neurological Disorders

Journal

Publisher

MDPI
DOI: 10.3390/ijms21175982

Keywords

bile acid receptors; neuroprotective; tauroursodeoxycholic acid; ursodeoxycholic acid; alzheimer's disease; parkinson's disease; multiple sclerosis; hepatic encephalopathy

Funding

  1. NIH [DK082435, DK112803]
  2. VA Merit award from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service [BX002638]

Ask authors/readers for more resources

Bile acids are commonly known as digestive agents for lipids. The mechanisms of bile acids in the gastrointestinal track during normal physiological conditions as well as hepatic and cholestatic diseases have been well studied. Bile acids additionally serve as ligands for signaling molecules such as nuclear receptor Farnesoid X receptor and membrane-bound receptors, Takeda G-protein-coupled bile acid receptor and sphingosine-1-phosphate receptor 2. Recent studies have shown that bile acid signaling may also have a prevalent role in the central nervous system. Some bile acids, such as tauroursodeoxycholic acid and ursodeoxycholic acid, have shown neuroprotective potential in experimental animal models and clinical studies of many neurological conditions. Alterations in bile acid metabolism have been discovered as potential biomarkers for prognosis tools as well as the expression of various bile acid receptors in multiple neurological ailments. This review explores the findings of recent studies highlighting bile acid-mediated therapies and bile acid-mediated signaling and the roles they play in neurodegenerative and neurological diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available